Wordt geladen...

SAT-500 Response to Tocilizumab Retreatment in Refractory Thyroid Eye Disease

Background: The current standard of care for moderate to severe thyroid eye disease (TED) is intravenous methylprednisolone (IVMP), though alternative immunosuppressive options are emerging. In a recent randomized trial, Tocilizumab (TCZ), an anti-IL-6 receptor antibody, demonstrated improved effica...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Endocr Soc
Hoofdauteurs: Kaplan, Daniel, Erickson, Benjamin, Kossler, Andrea, Chen, Julie, Dosiou, Chrysoula
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2020
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7207507/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1316
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!